Strategies and progresses for enhancing targeted antibiotic delivery

A Nazli, DL He, D Liao, MZI Khan, C Huang… - Advanced drug delivery …, 2022 - Elsevier
Antibiotic resistance is a global health issue and a potential risk for society. Antibiotics
administered through conventional formulations are devoid of targeting effect and often …

Impact of dendrimers on solubility of hydrophobic drug molecules

S Choudhary, L Gupta, S Rani, K Dave… - Frontiers in …, 2017 - frontiersin.org
Adequate aqueous solubility has been one of the desired properties while selecting drug
molecules and other bio-actives for product development. Often solubility of a drug …

[HTML][HTML] Computational and experimental approaches for investigating nanoparticle-based drug delivery systems

M Ramezanpour, SSW Leung… - … et Biophysica Acta (BBA …, 2016 - Elsevier
Most therapeutic agents suffer from poor solubility, rapid clearance from the blood stream, a
lack of targeting, and often poor translocation ability across cell membranes. Drug/gene …

Dendrimers: amazing platforms for bioactive molecule delivery systems

C Sandoval-Yañez, C Castro Rodriguez - Materials, 2020 - mdpi.com
Today, dendrimers are the main nanoparticle applied to drug delivery systems. The
physicochemical characteristics of dendrimers and their versatility structural modification …

Application of nanotechnology in drug delivery systems for respiratory diseases

MX Luo, S Hua, QY Shang - Molecular Medicine …, 2021 - spandidos-publications.com
Respiratory disease is a common disease with a high incidence worldwide, which is a
serious threat to human health, and is considered a societal and economic burden. The …

Advanced therapeutic strategies for chronic lung disease using nanoparticle-based drug delivery

JY Yhee, J Im, RS Nho - Journal of clinical medicine, 2016 - mdpi.com
Chronic lung diseases include a variety of obstinate and fatal diseases, including asthma,
chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), idiopathic pulmonary …

The formulation of nanomedicines for treating tuberculosis

A Costa, M Pinheiro, J Magalhães, R Ribeiro… - Advanced drug delivery …, 2016 - Elsevier
Recent estimates indicate that tuberculosis (TB) is the leading cause of death worldwide,
alongside the human immunodeficiency virus (HIV) infection. The current treatment is …

An insight into advances in developing nanotechnology based therapeutics, drug delivery, diagnostics and vaccines: multidimensional applications in tuberculosis …

H Chopra, YK Mohanta, PR Rauta, R Ahmed… - Pharmaceuticals, 2023 - mdpi.com
Tuberculosis (TB), one of the deadliest contagious diseases, is a major concern worldwide.
Long-term treatment, a high pill burden, limited compliance, and strict administration …

[HTML][HTML] Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: Emerging need for novel drug delivery approaches

K Dua, VK Rapalli, SD Shukla, G Singhvi… - Biomedicine & …, 2018 - Elsevier
Tuberculosis (caused by Mycobacterium tuberculosis, Mtb) treatment involves multiple drug
regimens for a prolonged period. However, the therapeutic benefit is often limited by poor …

Drug-dendrimer complexes and conjugates: Detailed furtherance through theory and experiments

RY Sathe, PV Bharatam - Advances in colloid and interface science, 2022 - Elsevier
Dendritic nanovectors-based drug delivery has gained significant attention in the past
couple of decades. Dendrimers play a crucial role in deciding the solubility of sparingly …